Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 203,962Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Blake Cassels & Graydon LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 200 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 400 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 600 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 800 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1000 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1200 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1400 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

Selexipag

Brand Name : UPTRAVI

Patent Number : 2445344

Filing Date : 2002-04-25

Strength per Unit : 1600 ?g

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-04-25

Date Granted : 2011-07-26

blank